Tissue Inhibitor of Metalloproteinase 1 Adenoviral Gene Therapy Alone Is Equally Effective in Reducing Restenosis as Combination Gene Therapy in a Rabbit Restenosis Model-Reference-Cited by-同舟云学术

Tissue Inhibitor of Metalloproteinase 1 Adenoviral Gene Therapy Alone Is Equally Effective in Reducing Restenosis as Combination Gene Therapy in a Rabbit Restenosis Model

Published:2005 Issue:5 Volume:42 Page:361-367
ISSN:1018-1172
Container-title:Journal of Vascular Research
language:en
Short-container-title:J Vasc Res

Author:

Puhakka Hanna L.,Turunen Päivi,Rutanen Juha,Hiltunen Mikko O.,Turunen Mikko P.,Ylä-Herttuala Seppo

Publisher

S. Karger AG

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference34 articles.

1. Narins CR, Holmes DR Jr, Topol EJ: A call for provisional stenting: the balloon is back! Circulation 1998;97:1298-1305.

2. Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study11See Appendix Afor the list of participants in the MIRACL study. That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction

3. The Emerging Concept of Vascular Remodeling

4. Mechanisms and prevention of restenosis: from experimental models to clinical practice

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in stent-mediated gene delivery;Expert Opinion on Drug Delivery;2016-02-16

2. Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis;Theranostics;2014

3. Gene- and Cell-Based Therapy for Cardiovascular Disease;Post-Genomic Cardiology;2014

4. Gene therapy for cardiovascular disease: Perspectives and potential;Vascular Pharmacology;2013-03

5. Nanotechnology-Based Gene-Eluting Stents;Molecular Pharmaceutics;2013-02-26